⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

June 1, 2023The LancetOpen Access

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider Marivic Narciso-Abraham Sandra Hadl Robert P. McMahon Sebastian Toepfer Ulrike Fuchs Romana Hochreiter Annegret Bitzer Karin Kosulin Julian Larcher‐Senn Robert M. Mader Katrin Dubischar Oliver Zoihsl Juan-Carlos Jaramillo Susanne Eder-Lingelbach Vera Buerger Nina Wressnigg

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Valneva, Coalition for Epidemic Preparedness Innovation, and EU Horizon 2020.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schneider et al. (2023) studied this question.

synapsesocial.com/papers/69d915cbea2783c07da3bfe1 https://doi.org/10.1016/s0140-6736(23)00641-4

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1ChikungunyaOriginal Research · 2019 · 241 citations
2Chikungunya Infection in TravelersOriginal Research · 2006 · 164 citations
3The global emergence of Chikungunya infection: An integrated viewReview · 2021 · 59 citations
4Prophylaxis and Therapy for Chikungunya Virus InfectionOriginal Research · 2009 · 257 citations
5Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month PeriodRetrospective Study · 2009 · 417 citations
6Chikungunya virus and prospects for a vaccineOriginal Research · 2012 · 298 citations
7Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virusOriginal Research · 2017 · 117 citations
8The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccinesSystematic Review · 2022 · 173 citations
9Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trialThe Lancet · 2022
10Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk (SYNCHRONIZE-CVOT): a double-blind, randomised, placebo-controlled, phase 3 trialThe Lancet · 2026

More from The Lancet

More from Valneva (Austria)